- Report
- August 2025
- 195 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 195 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 195 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 180 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 189 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 192 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 188 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 197 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 181 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- April 2025
- 200 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- February 2025
- 200 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2649EUR$3,000USD£2,299GBP
- Report
- September 2024
- 138 Pages
Global
From €2648EUR$2,999USD£2,298GBP
- Report
- September 2025
- 279 Pages
Global
From €5165EUR$5,850USD£4,482GBP
- Report
- September 2025
- 488 Pages
Global
From €5165EUR$5,850USD£4,482GBP
- Report
- September 2025
- 174 Pages
Global
From €5165EUR$5,850USD£4,482GBP
- Report
- September 2025
- 282 Pages
Global
From €5165EUR$5,850USD£4,482GBP
- Report
- September 2025
- 192 Pages
Global
From €5165EUR$5,850USD£4,482GBP
- Report
- September 2025
- 282 Pages
Global
From €5165EUR$5,850USD£4,482GBP
- Report
- September 2025
- 466 Pages
Global
From €5165EUR$5,850USD£4,482GBP

The Peptide market is a subset of the biopharmaceutical industry, which focuses on the development and production of therapeutic proteins and peptides. Peptides are short chains of amino acids that are used to treat a variety of diseases, including cancer, diabetes, and autoimmune disorders. Peptides are typically produced through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Peptide market is highly competitive, with a number of companies offering a variety of products. Companies in the market are focused on developing and manufacturing peptides for therapeutic use, as well as providing services such as peptide synthesis and purification. Additionally, some companies are involved in the development of peptide-based drug delivery systems.
Notable companies in the Peptide market include Novo Nordisk, Merck, Sanofi, and Pfizer. Other companies include AbbVie, Amgen, and Genentech. Show Less Read more